Cite
MLA Citation
Mark H Wilcox et al.. “Influence of Diagnostic Method on Outcomes in Phase 3 Clinical Trials of Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infection: A Post Hoc Analysis of MODIFY I/II.” Open forum infectious diseases, vol. 6, 2019, p. . http://access.bl.uk/ark:/81055/vdc_100094069603.0x000024